γ-secretase-regulated signaling typified by notch signaling in the immune system

Current Stem Cell Research and Therapy

Volumn 8, Issue 5, 2013, Pages 341-356

  Nagase, Hisashi ^a   Nakayama, Kohzo ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

secretase; secretase regulated signaling; Intracellular domain (ICD); Notch signaling; The regulated intramem brane proteolysis (RIP) mechanism; Type 1 transmembrane proteins

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CD4 ANTIGEN; CD8 ANTIGEN; COLONY STIMULATING FACTOR 1; CXCL16 CHEMOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FRACTALKINE; GAMMA INTERFERON; GAMMA SECRETASE; GRANZYME B; HERMES ANTIGEN; HLA A2 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 17; LEUKOSIALIN; MEMBRANE COFACTOR PROTEIN; NICASTRIN; NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; NOTCH4 RECEPTOR; PERFORIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR RUNX1; CD44 PROTEIN, HUMAN; SECRETASE;

ADIPOCYTE; ALLOIMMUNITY; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL MATURATION; CELL MEMBRANE; COLONY FORMING CELL; CYTOKINE PRODUCTION; DROSOPHILA; ENDOTHELIUM CELL; ERYTHROCYTE; FIBROBLAST; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; LEISHMANIA MAJOR; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; OSTEOBLAST; PARASITE CLEARANCE; POLARIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN METABOLISM; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH17 CELL; TH2 CELL; THYMUS; TOXOPLASMA GONDII; GENETICS; HEMATOPOIESIS; METABOLISM; NERVE CELL;

AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANTIGENS, CD44; APOPTOSIS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNE SYSTEM; NEURONS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

EID: 84888107325     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574888X113089990054     Document Type: Article

References (167)

1. Mohr OL. Character Changes Caused by Mutation of an Entire Region of a Chromosome in Drosophila. Genetics 1919; 4(3): 275-82.
2. Bolos V, Grego-Bessa J, de la Pompa JL. Notch signaling in development and cancer. Endocr Rev 2007; 28(3): 339-63.
3. Ellisen LW, Bird J, West DC, et al. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 1991; 66(4): 649-61.
4. Van Vlierberghe P, Ferrando A. The molecular basis of T cell acute lymphoblastic leukemia. J Clin Invest 2012; 122(10): 3398-406.
5. Levitan D, Greenwald I. Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 1995; 377(6547): 351-4.
6. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995; 375(6534): 754-60.
7. Levy-Lahad E, Wasco W, Poorkaj P, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995; 269(5226): 973-7.
8. Rogaev EI, Sherrington R, Rogaeva EA, et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995; 376(6543): 775-8.
9. Selkoe D, Kopan R. Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration. Annu Rev Neurosci 2003; 26: 565-97.
10. Nakayama K, Nagase H, Hiratochi M, Koh CS, Ohkawara T. Similar mechanisms regulated by gamma-secretase are involved in both directions of the bi-directional Notch-Delta signaling pathway as well as play a potential role in signaling events involving type 1 transmembrane proteins. Curr Stem Cell Res Ther 2008; 3(4): 288-302.
11. Maillard I, Adler SH, Pear WS. Notch and the immune system. Immunity 2003; 19(6): 781-91.
12. Suzuki T, Chiba S. Notch signaling in hematopoietic stem cells. Int J Hematol 2005; 82(4): 285-94.
13. Tanigaki K, Honjo T. Regulation of lymphocyte development by Notch signaling. Nat Immunol 2007; 8(5): 451-6.
14. Radtke F, Fasnacht N, Macdonald HR. Notch signaling in the immune system. Immunity 2010; 32(1): 14-27.
15. Nagase H, Koh CS, Nakayama K. gamma-Secretase-regulated signaling pathways, such as notch signaling, mediate the differentiation of hematopoietic stem cells, development of the immune system, and peripheral immune responses. Curr Stem Cell Res Ther 2011; 6(2): 131-41.
16. Amsen D, Antov A, Flavell RA. The different faces of Notch in Thelper-cell differentiation. Nat Rev Immunol 2009; 9(2): 116-24.
17. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999; 284(5415): 770-6.
18. Justice NJ, Jan YN. Variations on the Notch pathway in neural development. Curr Opin Neurobiol 2002; 12(1): 64-70.
19. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 1997; 20(4): 154-9.
20. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001; 81(2): 741-66.
21. Struhl G, Adachi A. Requirements for presenilin-dependent cleavage of notch and other transmembrane proteins. Mol Cell 2000; 6(3): 625-36.
22. Haapasalo A, Kovacs DM. The many substrates of presenilin/ gamma-secretase. J Alzheimers Dis 2011; 25(1): 3-28.
23. McCarthy JV, Twomey C, Wujek P. Presenilin-dependent regulated intramembrane proteolysis and gamma-secretase activity. Cell Mol Life Sci 2009; 66(9): 1534-55.
24. Lleo A. Activity of gamma-secretase on substrates other than APP. Curr Top Med Chem 2008; 8(1): 9-16.
25. Parks AL, Curtis D. Presenilin diversifies its portfolio. Trends Genet 2007; 23(3): 140-50.
26. Selkoe DJ, Wolfe MS. Presenilin: running with scissors in the membrane. Cell 2007; 131(2): 215-21.
27. Shah S, Lee SF, Tabuchi K, et al. Nicastrin functions as a gammasecretase-substrate receptor. Cell 2005; 122(3): 435-47.
28. Nakayama K, Nagase H, Koh CS, Ohkawara T. gamma-Secretaseregulated mechanisms similar to notch signaling may play a role in signaling events, including APP signaling, which leads to Alzheimer's disease. Cell Mol Neurobiol 2011; 31(6): 887-900.
29. Hadland BK, Manley NR, Su D, et al. Gamma-secretase inhibitors repress thymocyte development. Proc Natl Acad Sci USA 2001; 98(13): 7487-91.
30. Wong GT, Manfra D, Poulet FM, et al. Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation. J Biol Chem 2004; 279(13): 12876-82.
31. Qyang Y, Chambers SM, Wang P, et al. Myeloproliferative disease in mice with reduced presenilin gene dosage: effect of gammasecretase blockage. Biochemistry 2004; 43(18): 5352-9.
32. Tournoy J, Bossuyt X, Snellinx A, et al. Partial loss of presenilins causes seborrheic keratosis and autoimmune disease in mice. Hum Mol Genet 2004; 13(13): 1321-31.
33. Okamoto I, Kawano Y, Murakami D, et al. Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway. J Cell Biol 2001; 155(5): 755-62.
34. Murakami D, Okamoto I, Nagano O, et al. Presenilin-dependent gamma-secretase activity mediates the intramembranous cleavage of CD44. Oncogene 2003; 22(10): 1511-6.
35. Nagano O, Saya H. Mechanism and biological significance of CD44 cleavage. Cancer Sci 2004; 95(12): 930-5.
36. Wharton KA, Johansen KM, Xu T, Artavanis-Tsakonas S. Nucleotide sequence from the neurogenic locus notch implies a gene product that shares homology with proteins containing EGF-like repeats. Cell 1985; 43(3 Pt 2): 567-81.
37. Rebay I, Fleming RJ, Fehon RG, Cherbas L, Cherbas P, Artavanis-Tsakonas S. Specific EGF repeats of Notch mediate interactions with Delta and Serrate: implications for Notch as a multifunctional receptor. Cell 1991; 67(4): 687-99.
38. Logeat F, Bessia C, Brou C, et al. The Notch1 receptor is cleaved constitutively by a furin-like convertase. Proc Natl Acad Sci USA 1998; 95(14): 8108-12.
39. Brown MS, Ye J, Rawson RB, Goldstein JL. Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 2000; 100(4): 391-8.
40. Brou C, Logeat F, Gupta N, et al. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrinmetalloprotease TACE. Mol Cell 2000; 5(2): 207-16.
41. Mumm JS, Schroeter EH, Saxena MT, et al. A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol Cell 2000; 5(2): 197-206.
42. Kopan R, Schroeter EH, Weintraub H, Nye JS. Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain. Proc Natl Acad Sci USA 1996; 93(4): 1683-8.
43. Okochi M, Steiner H, Fukumori A, et al. Presenilins mediate a dual intramembranous gamma-secretase cleavage of Notch-1. EMBO J 2002; 21(20): 5408-16.
44. Schroeter EH, Kisslinger JA, Kopan R. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 1998; 393(6683): 382-6.
45. Hsieh JJ, Henkel T, Salmon P, Robey E, Peterson MG, Hayward SD. Truncated mammalian Notch1 activates CBF1/RBPJkrepressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2. Mol Cell Biol 1996; 16(3): 952-9.
46. Wu L, Aster JC, Blacklow SC, Lake R, Artavanis-Tsakonas S, Griffin JD. MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors. Nat Genet 2000; 26(4): 484-9.
47. Wallberg AE, Pedersen K, Lendahl U, Roeder RG. p300 and PCAF act cooperatively to mediate transcriptional activation from chromatin templates by notch intracellular domains in vitro. Mol Cell Biol 2002; 22(22): 7812-9.
48. Kageyama R, Ohtsuka T, Kobayashi T. The Hes gene family: repressors and oscillators that orchestrate embryogenesis. Development 2007; 134(7): 1243-51.
49. Deftos ML, Huang E, Ojala EW, Forbush KA, Bevan MJ. Notch1 signaling promotes the maturation of CD4 and CD8 SP thymocytes. Immunity 2000; 13(1): 73-84.
50. Campese AF, Garbe AI, Zhang F, Grassi F, Screpanti I, von Boehmer H. Notch1-dependent lymphomagenesis is assisted by but does not essentially require pre-TCR signaling. Blood 2006; 108(1): 305-10.
51. Amsen D, Blander JM, Lee GR, Tanigaki K, Honjo T, Flavell RA. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 2004; 117(4): 515-26.
52. Tanaka S, Tsukada J, Suzuki W, et al. The interleukin-4 enhancer CNS-2 is regulated by Notch signals and controls initial expression in NKT cells and memory-type CD4 T cells. Immunity 2006; 24(6): 689-701.
53. Minter LM, Turley DM, Das P, et al. Inhibitors of gammasecretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21. Nat Immunol 2005; 6(7): 680-8.
54. Amsen D, Antov A, Jankovic D, et al. Direct regulation of Gata3 expression determines the T helper differentiation potential of Notch. Immunity 2007; 27(1): 89-99.
55. Fang TC, Yashiro-Ohtani Y, Del Bianco C, Knoblock DM, Blacklow SC, Pear WS. Notch directly regulates Gata3 expression during T helper 2 cell differentiation. Immunity 2007; 27(1): 100-10.
56. Mukherjee S, Schaller MA, Neupane R, Kunkel SL, Lukacs NW. Regulation of T cell activation by Notch ligand, DLL4, promotes IL-17 production and Rorc activation. J Immunol 2009; 182(12): 7381-8.
57. Renstrom J, Kroger M, Peschel C, Oostendorp RA. How the niche regulates hematopoietic stem cells. Chem Biol Interact 2010; 184(1-2): 7-15.
58. Nakamura-Ishizu A, Suda T. Hematopoietic stem cell niche: an interplay among a repertoire of multiple functional niches. Biochim Biophys Acta 2013; 1830(2): 2404-9.
59. Kumano K, Chiba S, Kunisato A, et al. Notch1 but not Notch2 is essential for generating hematopoietic stem cells from endothelial cells. Immunity 2003; 18(5): 699-711.
60. Robert-Moreno A, Espinosa L, de la Pompa JL, Bigas A. RBPjkappa-dependent Notch function regulates Gata2 and is essential for the formation of intra-embryonic hematopoietic cells. Development 2005; 132(5): 1117-26.
61. Robert-Moreno A, Guiu J, Ruiz-Herguido C, et al. Impaired embryonic haematopoiesis yet normal arterial development in the absence of the Notch ligand Jagged1. EMBO J 2008; 27(13): 1886-95.
62. Guiu J, Shimizu R, D'Altri T, et al. Hes repressors are essential regulators of hematopoietic stem cell development downstream of Notch signaling. J Exp Med 2013; 210(1): 71-84.
63. Varnum-Finney B, Purton LE, Yu M, et al. The Notch ligand, Jagged-1, influences the development of primitive hematopoietic precursor cells. Blood 1998; 91(11): 4084-91.
64. Karanu FN, Murdoch B, Gallacher L, et al. The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells. J Exp Med 2000; 192(9): 1365-72.
65. Karanu FN, Murdoch B, Miyabayashi T, et al. Human homologues of Delta-1 and Delta-4 function as mitogenic regulators of primitive human hematopoietic cells. Blood 2001; 97(7): 1960-7.
66. Suzuki T, Yokoyama Y, Kumano K, et al. Highly efficient ex vivo expansion of human hematopoietic stem cells using Delta1-Fc chimeric protein. Stem Cells 2006; 24(11): 2456-65.
67. Carlesso N, Aster JC, Sklar J, Scadden DT. Notch1-induced delay of human hematopoietic progenitor cell differentiation is associated with altered cell cycle kinetics. Blood 1999; 93(3): 838-48.
68. Varnum-Finney B, Xu L, Brashem-Stein C, et al. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Nat Med 2000; 6(11): 1278-81.
69. Stier S, Cheng T, Dombkowski D, Carlesso N, Scadden DT. Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome. Blood 2002; 99(7): 2369-78.
70. Kunisato A, Chiba S, Nakagami-Yamaguchi E, et al. HES-1 preserves purified hematopoietic stem cells ex vivo and accumulates side population cells in vivo. Blood 2003; 101(5): 1777-83.
71. Calvi LM, Adams GB, Weibrecht KW, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425(6960): 841-6.
72. Han H, Tanigaki K, Yamamoto N, et al. Inducible gene knockout of transcription factor recombination signal binding protein-J reveals its essential role in T versus B lineage decision. Int Immunol 2002; 14(6): 637-45.
73. Mancini SJ, Mantei N, Dumortier A, Suter U, MacDonald HR, Radtke F. Jagged1-dependent Notch signaling is dispensable for hematopoietic stem cell self-renewal and differentiation. Blood 2005; 105(6): 2340-2.
74. Maillard I, Koch U, Dumortier A, et al. Canonical notch signaling is dispensable for the maintenance of adult hematopoietic stem cells. Cell Stem Cell 2008; 2(4): 356-66.
75. Boehm T, Bleul CC. Thymus-homing precursors and the thymic microenvironment. Trends Immunol 2006; 27(10): 477-84.
76. Radtke F, Wilson A, Stark G, et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 1999; 10(5): 547-58.
77. Wilson A, MacDonald HR, Radtke F. Notch 1-deficient common lymphoid precursors adopt a B cell fate in the thymus. J Exp Med 2001; 194(7): 1003-12.
78. Pui JC, Allman D, Xu L, et al. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity 1999; 11(3): 299-308.
79. Hozumi K, Mailhos C, Negishi N, et al. Delta-like 4 is indispensable in thymic environment specific for T cell development. J Exp Med 2008; 205(11): 2507-13.
80. Koch U, Fiorini E, Benedito R, et al. Delta-like 4 is the essential, nonredundant ligand for Notch1 during thymic T cell lineage commitment. J Exp Med 2008; 205(11): 2515-23.
81. Billiard F, Kirshner JR, Tait M, et al. Ongoing Dll4-Notch signaling is required for T-cell homeostasis in the adult thymus. Eur J Immunol 2011; 41(8): 2207-16.
82. Sambandam A, Maillard I, Zediak VP, et al. Notch signaling controls the generation and differentiation of early T lineage progenitors. Nat Immunol 2005; 6(7): 663-70.
83. Tan JB, Visan I, Yuan JS, Guidos CJ. Requirement for Notch1 signals at sequential early stages of intrathymic T cell development. Nat Immunol 2005; 6(7): 671-9.
84. Kuroda K, Han H, Tani S, et al. Regulation of marginal zone B cell development by MINT, a suppressor of Notch/RBP-J signaling pathway. Immunity 2003; 18(2): 301-12.
85. Oswald F, Kostezka U, Astrahantseff K, et al. SHARP is a novel component of the Notch/RBP-Jkappa signalling pathway. EMBO J 2002; 21(20): 5417-26.
86. Tsuji M, Shinkura R, Kuroda K, Yabe D, Honjo T. Msx2-interacting nuclear target protein (Mint) deficiency reveals negative regulation of early thymocyte differentiation by Notch/RBP-J signaling. Proc Natl Acad Sci U S A 2007; 104(5): 1610-5.
87. Wolfer A, Wilson A, Nemir M, MacDonald HR, Radtke F. Inactivation of Notch1 impairs VDJbeta rearrangement and allows pre-TCR-independent survival of early alpha beta Lineage Thymocytes. Immunity 2002; 16(6): 869-79.
88. Tanigaki K, Tsuji M, Yamamoto N, et al. Regulation of alphabeta/ gammadelta T cell lineage commitment and peripheral T cell responses by Notch/RBP-J signaling. Immunity 2004; 20(5): 611-22.
89. Maillard I, Tu L, Sambandam A, et al. The requirement for Notch signaling at the beta-selection checkpoint in vivo is absolute and independent of the pre-T cell receptor. J Exp Med 2006; 203(10): 2239-45.
90. Michie AM, Chan AC, Ciofani M, et al. Constitutive Notch signalling promotes CD4 CD8 thymocyte differentiation in the absence of the pre-TCR complex, by mimicking pre-TCR signals. Int Immunol 2007; 19(12): 1421-30.
91. Fowlkes BJ, Robey EA. A reassessment of the effect of activated Notch1 on CD4 and CD8 T cell development. J Immunol 2002; 169(4): 1817-21.
92. Robey E, Chang D, Itano A, et al. An activated form of Notch influences the choice between CD4 and CD8 T cell lineages. Cell 1996; 87(3): 483-92.
93. Deftos ML, He YW, Ojala EW, Bevan MJ. Correlating notch signaling with thymocyte maturation. Immunity 1998; 9(6): 777-86.
94. Izon DJ, Punt JA, Xu L, et al. Notch1 regulates maturation of CD4+ and CD8+ thymocytes by modulating TCR signal strength. Immunity 2001; 14(3): 253-64.
95. Adler SH, Chiffoleau E, Xu L, et al. Notch signaling augments T cell responsiveness by enhancing CD25 expression. J Immunol 2003; 171(6): 2896-903.
96. Palaga T, Miele L, Golde TE, Osborne BA. TCR-mediated Notch signaling regulates proliferation and IFN-gamma production in peripheral T cells. J Immunol 2003; 171(6): 3019-24.
97. Eagar TN, Tang Q, Wolfe M, He Y, Pear WS, Bluestone JA. Notch 1 signaling regulates peripheral T cell activation. Immunity 2004; 20(4): 407-15.
98. Rutz S, Mordmuller B, Sakano S, Scheffold A. Notch ligands Delta-like1, Delta-like4 and Jagged1 differentially regulate activation of peripheral T helper cells. Eur J Immunol 2005; 35(8): 2443-51.
99. Maekawa Y, Tsukumo S, Chiba S, et al. Delta1-Notch3 interactions bias the functional differentiation of activated CD4+ T cells. Immunity 2003; 19(4): 549-59.
100. Skokos D, Nussenzweig MC. CD8-DCs induce IL-12-independent Th1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPS. J Exp Med 2007; 204(7): 1525-31.
101. [] Auderset F, Schuster S, Coutaz M, et al. Redundant Notch1 and Notch2 signaling is necessary for IFNgamma secretion by T helper 1 cells during infection with Leishmania major. PLoS Pathog 2012; 8(3): e1002560.
102. Shin HM, Minter LM, Cho OH, et al. Notch1 augments NFkappaB activity by facilitating its nuclear retention. EMBO J 2006; 25(1): 129-38.
103. Ong CT, Sedy JR, Murphy KM, Kopan R. Notch and presenilin regulate cellular expansion and cytokine secretion but cannot instruct Th1/Th2 fate acquisition. PLoS One 2008; 3(7): e2823.
104. Keerthivasan S, Suleiman R, Lawlor R, et al. Notch signaling regulates mouse and human Th17 differentiation. J Immunol 2011; 187(2): 692-701.
105. Sauma D, Ramirez A, Alvarez K, Rosemblatt M, Bono MR. Notch signalling regulates cytokine production by CD8+ and CD4+ T cells. Scand J Immunol 2012; 75(4): 389-400.
106. Shibata K, Yamada H, Sato T, et al. Notch-Hes1 pathway is required for the development of IL-17-producing gammadelta T cells. Blood 2011; 118(3): 586-93.
107. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008; 133(5): 775-87.
108. Anastasi E, Campese AF, Bellavia D, et al. Expression of activated Notch3 in transgenic mice enhances generation of T regulatory cells and protects against experimental autoimmune diabetes. J Immunol 2003; 171(9): 4504-11.
109. Kared H, Adle-Biassette H, Fois E, et al. Jagged2-expressing hematopoietic progenitors promote regulatory T cell expansion in the periphery through notch signaling. Immunity 2006; 25(5): 823-34.
110. Samon JB, Champhekar A, Minter LM, et al. Notch1 and TGFbeta1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cells. Blood 2008; 112(5): 1813-21.
111. Del Papa B, Sportoletti P, Cecchini D, et al. Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction. Eur J Immunol 2013; 43(1): 182-7.
112. Barbarulo A, Grazioli P, Campese AF, et al. Notch3 and canonical NF-kappaB signaling pathways cooperatively regulate Foxp3 transcription. J Immunol 2011; 186(11): 6199-206.
113. Haque R, Lei F, Xiong X, et al. Programming of regulatory T cells from pluripotent stem cells and prevention of autoimmunity. J Immunol 2012; 189(3): 1228-36.
114. Tu L, Fang TC, Artis D, et al. Notch signaling is an important regulator of type 2 immunity. J Exp Med 2005; 202(8): 1037-42.
115. Nagase H, Jones KM, Anderson CF, Noben-Trauth N. Despite increased CD4+Foxp3+ cells within the infection site, BALB/c IL-4 receptor-deficient mice reveal CD4+Foxp3-negative T cells as a source of IL-10 in Leishmania major susceptibility. J Immunol 2007; 179(4): 2435-44.
116. Anderson CF, Oukka M, Kuchroo VJ, Sacks D. CD4(+) CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med 2007; 204(2): 285-97.
117. Jankovic D, Kullberg MC, Feng CG, et al. Conventional Tbet(+) Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J Exp Med 2007; 204(2): 273-83.
118. Rutz S, Janke M, Kassner N, Hohnstein T, Krueger M, Scheffold A. Notch regulates IL-10 production by T helper 1 cells. Proc Natl Acad Sci USA 2008; 105(9): 3497-502.
119. Kassner N, Krueger M, Yagita H, et al. Cutting edge: Plasmacytoid dendritic cells induce IL-10 production in T cells via the Delta-like-4/Notch axis. J Immunol 2010; 184(2): 550-4.
120. Cho OH, Shin HM, Miele L, et al. Notch regulates cytolytic effector function in CD8+ T cells. J Immunol 2009; 182(6): 3380-9.
121. Maekawa Y, Minato Y, Ishifune C, et al. Notch2 integrates signaling by the transcription factors RBP-J and CREB1 to promote T cell cytotoxicity. Nat Immunol 2008; 9(10): 1140-7.
122. Kuijk LM, Verstege MI, Rekers NV, et al. Notch controls generation and function of human effector CD8+ T cells. Blood 2013; 121(14): 2638-46.
123. Wong KK, Carpenter MJ, Young LL, et al. Notch ligation by Delta1 inhibits peripheral immune responses to transplantation antigens by a CD8+ cell-dependent mechanism. J Clin Invest 2003; 112(11): 1741-50.
124. Mathieu M, Cotta-Grand N, Daudelin JF, Thebault P, Labrecque N. Notch signaling regulates PD-1 expression during CD8(+) T-cell activation. Immunol Cell Biol 2013; 91(1): 82-8.
125. Iwatsubo T. The gamma-secretase complex: machinery for intramembrane proteolysis. Curr Opin Neurobiol 2004; 14(3): 379-83.
126. Kopan R, Ilagan MX. Gamma-secretase: proteasome of the membrane? Nat Rev Mol Cell Biol 2004; 5(6): 499-504.
127. Lee MK, Slunt HH, Martin LJ, et al. Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues. J Neurosci 1996; 16(23): 7513-25.
128. Yu G, Nishimura M, Arawaka S, et al. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing. Nature 2000; 407(6800): 48-54.
129. Hiratochi M, Nagase H, Kuramochi Y, Koh CS, Ohkawara T, Nakayama K. The Delta intracellular domain mediates TGFbeta/ Activin signaling through binding to Smads and has an important bi-directional function in the Notch-Delta signaling pathway. Nucleic Acids Res 2007; 35(3): 912-22.
130. Nakayama K, Ohkawara T, Hiratochi M, Koh CS, Nagase H. The intracellular domain of amyloid precursor protein induces neuronspecific apoptosis. Neurosci Lett 2008; 444(2): 127-31.
131. Ohkawara T, Nagase H, Koh CS, Nakayama K. The amyloid precursor protein intracellular domain alters gene expression and induces neuron-specific apoptosis. Gene 2011; 475(1): 1-9.
132. Nakayama K, Nagase H, Koh CS, Ohkawara T. gamma-Secretaseregulated signaling: Notch, APP, and Alzheimer's Disease. Curr Psycopharmacol 2012; 1(2): 155-66.
133. Ryan KA, Pimplikar SW. Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain. J Cell Biol 2005; 171(2): 327-35.
134. Ghosal K, Vogt DL, Liang M, Shen Y, Lamb BT, Pimplikar SW. Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain. Proc Natl Acad Sci USA 2009; 106(43): 18367-72.
135. Vogt DL, Thomas D, Galvan V, Bredesen DE, Lamb BT, Pimplikar SW. Abnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain. Neurobiol Aging 2011; 32(9): 1725-9.
136. Abbott A. Neuroscience: The plaque plan. Nature 2008; 456(7219): 161-4.
137. Holmes C, Boche D, Wilkinson D, et al. Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 2008; 372(9634): 216-23.
138. Yagi T, Giallourakis C, Mohanty S, et al. Defective signal transduction in B lymphocytes lacking presenilin proteins. Proc Natl Acad Sci USA 2008; 105(3): 979-84.
139. Beglopoulos V, Sun X, Saura CA, Lemere CA, Kim RD, Shen J. Reduced beta-amyloid production and increased inflammatory responses in presenilin conditional knock-out mice. J Biol Chem 2004; 279(45): 46907-14.
140. Jayadev S, Case A, Eastman AJ, et al. Presenilin 2 is the predominant gamma-secretase in microglia and modulates cytokine release. PLoS One 2010; 5(12): e15743.
141. Andersson CX, Fernandez-Rodriguez J, Laos S, Baeckstrom D, Haass C, Hansson GC. Shedding and gamma-secretase-mediated intramembrane proteolysis of the mucin-type molecule CD43. Biochem J 2005; 387(Pt 2): 377-84.
142. Weyand NJ, Calton CM, Higashi DL, Kanack KJ, So M. Presenilin/ gamma-secretase cleaves CD46 in response to Neisseria infection. J Immunol 2010; 184(2): 694-701.
143. Carey BW, Kim DY, Kovacs DM. Presenilin/gamma-secretase and alpha-secretase-like peptidases cleave human MHC Class I proteins. Biochem J 2007; 401(1): 121-7.
144. Schulte A, Schulz B, Andrzejewski MG, et al. Sequential processing of the transmembrane chemokines CX3CL1 and CXCL16 by alpha-and gamma-secretases. Biochem Biophys Res Commun 2007; 358(1): 233-40.
145. El Fiky A, Arch AE, Krolewski JJ. Intracellular domain of the IFNaR2 interferon receptor subunit mediates transcription via Stat2. J Cell Physiol 2005; 204(2): 567-73.
146. El Fiky A, Pioli P, Azam A, Yoo K, Nastiuk KL, Krolewski JJ. Nuclear transit of the intracellular domain of the interferon receptor subunit IFNaR2 requires Stat2 and Irf9. Cell Signal 2008; 20(7): 1400-8.
147. Saleh AZ, Fang AT, Arch AE, Neupane D, El Fiky A, Krolewski JJ. Regulated proteolysis of the IFNaR2 subunit of the interferonalpha receptor. Oncogene 2004; 23(42): 7076-86.
148. Elzinga BM, Twomey C, Powell JC, Harte F, McCarthy JV. Interleukin-1 receptor type 1 is a substrate for gamma-secretasedependent regulated intramembrane proteolysis. J Biol Chem 2009; 284(3): 1394-409.
149. Twomey C, Qian S, McCarthy JV. TRAF6 promotes ubiquitination and regulated intramembrane proteolysis of IL-1R1. Biochem Biophys Res Commun 2009; 381(3): 418-23.
150. Kuhn PH, Marjaux E, Imhof A, De Strooper B, Haass C, Lichtenthaler SF. Regulated intramembrane proteolysis of the interleukin-1 receptor II by alpha-, beta-, and gamma-secretase. J Biol Chem 2007; 282(16): 11982-95.
151. Wilhelmsen K, van der Geer P. Phorbol 12-myristate 13-acetateinduced release of the colony-stimulating factor 1 receptor cytoplasmic domain into the cytosol involves two separate cleavage events. Mol Cell Biol 2004; 24(1): 454-64.
152. Glenn G, van der Geer P. CSF-1 and TPA stimulate independent pathways leading to lysosomal degradation or regulated intramembrane proteolysis of the CSF-1 receptor. FEBS Lett 2007; 581(28): 5377-81.
153. Glenn G, van der Geer P. Toll-like receptors stimulate regulated intramembrane proteolysis of the CSF-1 receptor through Erk activation. FEBS Lett 2008; 582(6): 911-5.
154. Lammich S, Okochi M, Takeda M, et al. Presenilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an Abeta-like peptide. J Biol Chem 2002; 277(47): 44754-9.
155. Ikeuchi T, Sisodia SS. The Notch ligands, Delta1 and Jagged2, are substrates for presenilin-dependent gamma-secretase cleavage. J Biol Chem 2003; 278(10): 7751-4.
156. LaVoie MJ, Selkoe DJ. The Notch ligands, Jagged and Delta, are sequentially processed by alpha-secretase and presenilin/gammasecretase and release signaling fragments. J Biol Chem 2003; 278(36): 34427-37.
157. Six E, Ndiaye D, Laabi Y, et al. The Notch ligand Delta1 is sequentially cleaved by an ADAM protease and gamma-secretase. Proc Natl Acad Sci USA 2003; 100(13): 7638-43.
158. Chalaris A, Gewiese J, Paliga K, et al. ADAM17-mediated shedding of the IL6R induces cleavage of the membrane stub by gamma-secretase. Biochim Biophys Acta 2010; 1803(2): 234-45.
159. Hertweck MK, Erdfelder F, Kreuzer KA. CD44 in hematological neoplasias. Ann Hematol 2011; 90(5): 493-508.
160. Baaten BJ, Li CR, Deiro MF, Lin MM, Linton PJ, Bradley LM. CD44 regulates survival and memory development in Th1 cells. Immunity 2010; 32(1): 104-15.
161. Okamoto I, Kawano Y, Matsumoto M, et al. Regulated CD44 cleavage under the control of protein kinase C, calcium influx, and the Rho family of small G proteins. J Biol Chem 1999; 274(36): 25525-34.
162. Okamoto I, Kawano Y, Tsuiki H, et al. CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration. Oncogene 1999; 18(7): 1435-46.
163. Kawano Y, Okamoto I, Murakami D, et al. Ras oncoprotein induces CD44 cleavage through phosphoinositide 3-OH kinase and the rho family of small G proteins. J Biol Chem 2000; 275(38): 29628-35.
164. Cui W, Ke JZ, Zhang Q, Ke HZ, Chalouni C, Vignery A. The intracellular domain of CD44 promotes the fusion of macrophages. Blood 2006; 107(2): 796-805.
165. De Falco V, Tamburrino A, Ventre S, et al. CD44 proteolysis increases CREB phosphorylation and sustains proliferation of thyroid cancer cells. Cancer Res 2012; 72(6): 1449-58.
166. Miletti-Gonzalez KE, Murphy K, Kumaran MN, et al. Identification of function for CD44 intracytoplasmic domain (CD44-ICD): modulation of matrix metalloproteinase 9 (MMP-9) transcription via novel promoter response element. J Biol Chem 2012; 287(23): 18995-9007.
167. Seo W, Ziltener HJ. CD43 processing and nuclear translocation of CD43 cytoplasmic tail are required for cell homeostasis. Blood 2009; 114(17): 3567-77